IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 5,662.50% | -85.96% | |||
| Gross Profit | -4,800.00% | -133.33% | |||
| SG&A Expenses | 9.90% | -24.15% | |||
| Depreciation & Amortization | -47.73% | -5.71% | |||
| Other Operating Expenses | 5.74% | -43.25% | |||
| Total Operating Expenses | 4.09% | -36.63% | |||
| Operating Income | -0.61% | 34.94% | |||
| Income Before Tax | -181.85% | 53.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -181.85% | 52.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -181.85% | 52.08% | |||
| EBIT | -0.61% | 34.94% | |||
| EBITDA | 13.79% | 36.35% | |||
| EPS Basic | -150.42% | 65.95% | |||
| Normalized Basic EPS | 129.25% | 66.74% | |||
| EPS Diluted | -162.71% | 66.29% | |||
| Normalized Diluted EPS | 129.25% | 66.74% | |||
| Average Basic Shares Outstanding | 12.28% | 40.91% | |||
| Average Diluted Shares Outstanding | 12.28% | 40.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||